New rheumatoid arthritis severity gene identified by scientists
A new gene associated with disease severity in models of rheumatoid arthritis has been identified by experts, they report in the Annals of the Rheumatic Diseases. The discovery could provide a new pathway for treatment and a way to measure the prognosis of people diagnosed with the autoimmune condition.
Through a series of experiments the team has shown that the gene HIP1 is a driver in inflammatory arthritis severity. This is the first time that HIP1 has been implicated in arthritis severity and in cell invasiveness.
Previous research had found that increased HIP1 expression in certain cancers and correlated with worse prognosis in prostate cancer patients, so the findings also have relevance for cancer biology and the understanding of cancer cell invasion and metastasis.
“There have been major advances in the treatment of rheumatoid arthritis in the past 20 years, but disease remission still remains uncommon,” says Dr Percio Gulko, who is involved in the work. “Most drugs today target inflammation but often that is not enough to control disease.
“We are aiming for a novel way of treating the disease. One that targets the synovial fibroblast, while sparing the immune system outside the joint.”
Arthritis Digest Magazine was selected by Feedspot as one of the Top 5 Arthritis Blogs on the internet in 2018.
For more in-depth features, interviews and information, subscribe to Arthritis Digest magazine, a popular title that’s published six times a year. Click here for the digital version or tel 0845 643 8470 to order your had copy. You’ll know what your doctor is talking about, what new drugs are in the pipeline and be up to date on helpful products.